To test this hypothesis, an siRNA targeting KIF15, which reduced the expression of KIF15 in CRC cells (Supplementary Fig. S4c, d), or SB743921, a KIF15 inhibitor, was used to treat B7-H3-overexpressing CRC cells. The gene discussed is CD276; the disease is colorectal carcinoma.